Mitochondria in Their Prime Drive Venetoclax Response in Acute Myeloid Leukemia

Research output: Contribution to journal › Journal article › Research

Standard

Mitochondria in Their Prime Drive Venetoclax Response in Acute Myeloid Leukemia. / Kriegbaum, Mette C.; Wennerberg, Krister.

In: Cancer Cell, Vol. 38, No. 6, 2020, p. 776-778.

Research output: Contribution to journal › Journal article › Research

Harvard

Kriegbaum, MC & Wennerberg, K 2020, 'Mitochondria in Their Prime Drive Venetoclax Response in Acute Myeloid Leukemia', Cancer Cell, vol. 38, no. 6, pp. 776-778. https://doi.org/10.1016/j.ccell.2020.10.018

APA

Kriegbaum, M. C., & Wennerberg, K. (2020). Mitochondria in Their Prime Drive Venetoclax Response in Acute Myeloid Leukemia. Cancer Cell, 38(6), 776-778. https://doi.org/10.1016/j.ccell.2020.10.018

Vancouver

Kriegbaum MC, Wennerberg K. Mitochondria in Their Prime Drive Venetoclax Response in Acute Myeloid Leukemia. Cancer Cell. 2020;38(6):776-778. https://doi.org/10.1016/j.ccell.2020.10.018

Author

Kriegbaum, Mette C. ; Wennerberg, Krister. / Mitochondria in Their Prime Drive Venetoclax Response in Acute Myeloid Leukemia. In: Cancer Cell. 2020 ; Vol. 38, No. 6. pp. 776-778.

Bibtex

@article{ed2ccfb1a6f64b7b86d5db40d614ff19,
title = "Mitochondria in Their Prime Drive Venetoclax Response in Acute Myeloid Leukemia",
abstract = "Venetoclax has changed the clinical outlook for elderly and unfit patients with acute myeloid leukemia, but development of resistance is a challenge. In this issue of Cancer Cell, Bhatt et al. provide a general mechanism for how resistance emerges but also indications for how venetoclax-resistant cases may be treated.",
keywords = "RESISTANCE",
author = "Kriegbaum, {Mette C.} and Krister Wennerberg",
year = "2020",
doi = "10.1016/j.ccell.2020.10.018",
language = "English",
volume = "38",
pages = "776--778",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "6",

}

RIS

TY - JOUR

T1 - Mitochondria in Their Prime Drive Venetoclax Response in Acute Myeloid Leukemia

AU - Kriegbaum, Mette C.

AU - Wennerberg, Krister

PY - 2020

Y1 - 2020

N2 - Venetoclax has changed the clinical outlook for elderly and unfit patients with acute myeloid leukemia, but development of resistance is a challenge. In this issue of Cancer Cell, Bhatt et al. provide a general mechanism for how resistance emerges but also indications for how venetoclax-resistant cases may be treated.

AB - Venetoclax has changed the clinical outlook for elderly and unfit patients with acute myeloid leukemia, but development of resistance is a challenge. In this issue of Cancer Cell, Bhatt et al. provide a general mechanism for how resistance emerges but also indications for how venetoclax-resistant cases may be treated.

KW - RESISTANCE

U2 - 10.1016/j.ccell.2020.10.018

DO - 10.1016/j.ccell.2020.10.018

M3 - Journal article

C2 - 33321085

VL - 38

SP - 776

EP - 778

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 6

ER -

ID: 255049917